Correlation Between Takeda Pharmaceutical and HUTCHMED DRC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Takeda Pharmaceutical and HUTCHMED DRC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Takeda Pharmaceutical and HUTCHMED DRC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Takeda Pharmaceutical Co and HUTCHMED DRC, you can compare the effects of market volatilities on Takeda Pharmaceutical and HUTCHMED DRC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Takeda Pharmaceutical with a short position of HUTCHMED DRC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Takeda Pharmaceutical and HUTCHMED DRC.

Diversification Opportunities for Takeda Pharmaceutical and HUTCHMED DRC

-0.14
  Correlation Coefficient

Good diversification

The 3 months correlation between Takeda and HUTCHMED is -0.14. Overlapping area represents the amount of risk that can be diversified away by holding Takeda Pharmaceutical Co and HUTCHMED DRC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on HUTCHMED DRC and Takeda Pharmaceutical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Takeda Pharmaceutical Co are associated (or correlated) with HUTCHMED DRC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of HUTCHMED DRC has no effect on the direction of Takeda Pharmaceutical i.e., Takeda Pharmaceutical and HUTCHMED DRC go up and down completely randomly.

Pair Corralation between Takeda Pharmaceutical and HUTCHMED DRC

Considering the 90-day investment horizon Takeda Pharmaceutical Co is expected to generate 0.39 times more return on investment than HUTCHMED DRC. However, Takeda Pharmaceutical Co is 2.57 times less risky than HUTCHMED DRC. It trades about -0.07 of its potential returns per unit of risk. HUTCHMED DRC is currently generating about -0.28 per unit of risk. If you would invest  1,360  in Takeda Pharmaceutical Co on August 27, 2024 and sell it today you would lose (22.00) from holding Takeda Pharmaceutical Co or give up 1.62% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Takeda Pharmaceutical Co  vs.  HUTCHMED DRC

 Performance 
       Timeline  
Takeda Pharmaceutical 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Takeda Pharmaceutical Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain persistent and the latest mess on Wall Street may also be a sign of long-standing gains for the company institutional investors.
HUTCHMED DRC 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in HUTCHMED DRC are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy fundamental indicators, HUTCHMED DRC is not utilizing all of its potentials. The latest stock price disarray, may contribute to short-term losses for the investors.

Takeda Pharmaceutical and HUTCHMED DRC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Takeda Pharmaceutical and HUTCHMED DRC

The main advantage of trading using opposite Takeda Pharmaceutical and HUTCHMED DRC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Takeda Pharmaceutical position performs unexpectedly, HUTCHMED DRC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in HUTCHMED DRC will offset losses from the drop in HUTCHMED DRC's long position.
The idea behind Takeda Pharmaceutical Co and HUTCHMED DRC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Global Correlations
Find global opportunities by holding instruments from different markets
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules